To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults

NCT04885361 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease (COVID-19)

Interventions

BIOLOGICAL: CoVepiT (OSE13E)

Sponsor

OSE Immunotherapeutics